Spot Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Spot Trading’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$425K	Buy	33,500 +9,300	+38%	+$118K	0.01%	1765
2017 Q2	$287K	Buy	+24,200	New	+$301K	0.01%	1982
2017 Q1	–	Sell	-49,900	Closed	-$807K	–	3502
2016 Q4	$807K	Buy	49,900 +15,700	+46%	+$285K	0.02%	1095
2016 Q3	$620K	Sell	34,200 -200	-0.6%	-$3.91K	0.01%	1397
2016 Q2	$567K	Buy	+34,400	New	+$557K	0.01%	1535
2016 Q1	–	Sell	-20,700	Closed	-$449K	–	4276
2015 Q4	$449K	Sell	20,700 -128,900	-86%	-$2.51M	﹤0.01%	1997
2015 Q3	$2.96M	Buy	+149,600	New	+$4.73M	0.03%	830
2015 Q2	–	Sell	-8,100	Closed	-$210K	–	4426
2015 Q1	$210K	Buy	8,100 +7,100	+710%	+$130K	﹤0.01%	2714
2014 Q4	$13K	Buy	+1,000	New	+$12.5K	﹤0.01%	3648
2014 Q1	–	Sell	-98,000	Closed	-$747K	–	4664
2013 Q4	$747K	Buy	+98,000	New	+$529K	﹤0.01%	2183

Other funds holding HZNP

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BGIM

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Spot Trading's HZNP Position: Q3 2017 in Review

Spot Trading opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2017: 17,005 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #2186 among its holdings. This is a return to the name: Spot Trading previously reported a position in HZNP as recently as Q4 2016.

Spot Trading first reported a position in HZNP in Q4 2015 and has held it in 4 quarters since. The position peaked at $748K in Q4 2015. 181 funds tracked by Wall St. Rank hold HZNP as of Q3 2017.

Spot Trading held 17,005 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $216K as of Q3 2017.
Horizon Therapeutics Public Limited Company Ordinary Shares was a new Spot Trading position in Q3 2017.
Horizon Therapeutics Public Limited Company Ordinary Shares made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2186 holding.
Spot Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2015 and has held it in 4 quarters since.
Spot Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $748K in Q4 2015.
181 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.